Ikena Oncology
Trupti Lingaraj has over 19 years of experience in the pharmaceutical industry, starting as a Research Investigator at Millennium Pharmaceuticals, Inc. in 2002. Trupti then held various roles at Epizyme, including Principal Research Associate, Scientist, Senior Scientist, Principal Scientist, and Clinical Scientist. Most recently, Trupti worked at Ikena Oncology as a Clinical Scientist before becoming the Director of Clinical Development in 2023.
Trupti Lingaraj attended Indiana University Indianapolis from 1995 to 1998.
Ikena Oncology
Ikena is a targeted oncology company focused on developing novel cancer therapies targeting key signaling pathways that drive the formation and spread of cancer.